Loading...
Sionna Therapeutics, Inc.
SION•NASDAQ
HealthcareBiotechnology
$17.22
$1.19(7.42%)
Sionna Therapeutics, Inc. (SION) Stock Overview
Explore Sionna Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for SIONStats details for SION are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations
Strong Buy
Buy
Hold
Sell
Strong Sell
Price Targets
Low$45.00
Average$45.00
High$45.00
Company Profile
Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.
CEO
Mr. Michael Cloonan M.B.A.
Employees
41
Headquarters
21 Hickory Drive Suite 500, Waltham, MA
Founded
1970